X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS MERCK LTD DR. DATSONS LABS/
MERCK LTD
 
P/E (TTM) x -10.9 47.8 - View Chart
P/BV x 0.2 7.2 2.2% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 DR. DATSONS LABS   MERCK LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
MERCK LTD
Dec-16
DR. DATSONS LABS/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1261,060 11.8%   
Low Rs31623 5.0%   
Sales per share (Unadj.) Rs133.0632.4 21.0%  
Earnings per share (Unadj.) Rs0.245.7 0.3%  
Cash flow per share (Unadj.) Rs6.662.3 10.6%  
Dividends per share (Unadj.) Rs011.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs128.8388.8 33.1%  
Shares outstanding (eoy) m31.6616.60 190.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.3 44.2%   
Avg P/E ratio x516.118.4 2,804.0%  
P/CF ratio (eoy) x11.813.5 87.7%  
Price / Book Value ratio x0.62.2 28.1%  
Dividend payout %024.1 0.0%   
Avg Mkt Cap Rs m2,47713,969 17.7%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m561,487 3.8%   
Avg. sales/employee Rs ThNM6,631.9-  
Avg. wages/employee Rs ThNM939.2-  
Avg. net profit/employee Rs ThNM479.4-  
INCOME DATA
Net Sales Rs m4,21110,498 40.1%  
Other income Rs m79242 32.5%   
Total revenues Rs m4,28910,741 39.9%   
Gross profit Rs m5691,135 50.1%  
Depreciation Rs m204276 74.2%   
Interest Rs m4300-   
Profit before tax Rs m131,102 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6343 1.8%   
Profit after tax Rs m5759 0.6%  
Gross profit margin %13.510.8 124.9%  
Effective tax rate %48.031.1 154.2%   
Net profit margin %0.17.2 1.6%  
BALANCE SHEET DATA
Current assets Rs m6,8526,410 106.9%   
Current liabilities Rs m6,7118,828 76.0%   
Net working cap to sales %3.3-23.0 -14.5%  
Current ratio x1.00.7 140.6%  
Inventory Days Days16158 278.9%  
Debtors Days Days31838 829.6%  
Net fixed assets Rs m3,6731,406 261.2%   
Share capital Rs m317166 190.7%   
"Free" reserves Rs m3,7616,286 59.8%   
Net worth Rs m4,0786,455 63.2%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6338,828 143.1%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.2 28.0%   
Return on assets %3.48.6 40.1%  
Return on equity %0.111.8 1.0%  
Return on capital %7.717.1 44.9%  
Exports to sales %22.98.3 276.5%   
Imports to sales %14.321.0 67.9%   
Exports (fob) Rs m964869 110.9%   
Imports (cif) Rs m6022,209 27.2%   
Fx inflow Rs m964959 100.5%   
Fx outflow Rs m6072,612 23.2%   
Net fx Rs m357-1,653 -21.6%   
CASH FLOW
From Operations Rs m1,3451,070 125.6%  
From Investments Rs m-2,256-750 300.9%  
From Financial Activity Rs m-1,200-150 800.9%  
Net Cashflow Rs m-2,111171 -1,235.0%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 1.4 1.0 135.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 29.1 323.4%  
Shareholders   20,807 28,591 72.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  VENUS REMEDIES  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - GSK PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS